Q4/2023 12/31/2023 EPS -0.280 ZacksConsensus -0.350 ActVsEst 0.070 - Beat

Seer, Inc. - Class A (SEER)
Company Research
Source: Wall Street Horizon

Impact Snapshot
Event Time:
SEER
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SEER alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SEER alerts
High impacting Seer, Inc. - Class A news events
Weekly update
A roundup of the hottest topics
SEER
News
- Seer Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Outlook [Yahoo! Finance]Yahoo! Finance
- Seer Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 OutlookGlobeNewswire
- Seer to Participate in the TD Cowen 45th Annual Health Care ConferenceGlobeNewswire
- Seer to Feature Proteomic Advancements in Cancer and RNA Therapy Research among other Findings at US HUPO 2025 [Yahoo! Finance]Yahoo! Finance
- Seer to Feature Proteomic Advancements in Cancer and RNA Therapy Research among other Findings at US HUPO 2025GlobeNewswire
SEER
Earnings
- 2/27/25 - Beat
SEER
Sec Filings
- 3/3/25 - Form 10-K
- 2/27/25 - Form 8-K
- 2/20/25 - Form 4
- SEER's page on the SEC website